2m 2m 2m 2m 2m 2m 2m
GENELUX (GNLX)
NASDAQ
$2.80+$0.08 (+2.94%)
Price as of Aug 21, 2026 7:30 PM EDT- $123.1MMarket Cap
- -28.04%1-Year Change
- BiotechnologyIndustry
GENELUX (GNLX)
$2.80+$0.08 (+2.94%)
GNLX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.72 | ||
Change | -$0.02 (-0.73%) | ||
Open | $2.78 | ||
High | $2.81 | ||
Low | $2.68 | ||
Previous Close | $2.74 | ||
Volume | 223,747 | ||
30-Day Average Volume | 310,265 | ||
1-Week Change | -0.73% | ||
1-Month Change | -5.88% | ||
1-Year Change | -28.04% | ||
3-Year Change | -87.84% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 45.2M | ||
Total Assets | $26.2M | ||
Market Cap | $123.1M | ||
Enterprise Value | $113.9M | ||
Period: QTR TTM FY | |||
Revenue | $3,000.00 | ||
Net Income | -$9.5M | ||
Free Cash Flow | -$8.0M | ||
EBIT | -$9.5M | ||
EBITDA | -$9.5M | ||
Net Working Capital | $11.1M | ||
EPS | -$0.21 | ||
Enterprise Value/EBITDA | -12 | ||
Enterprise Value/Revenue | 37,961 | ||
P/B | 8 | ||
P/E | -13 | ||
PEG | 3 | ||
Price/Free Cash Flow | -15 | ||
Price/Operating Cash Flow | -19 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue